Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
12.9M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
10.2M
-
Shares change
-
-559K
-
Total reported value, excl. options
-
$28.1M
-
Value change
-
-$1.3M
-
Number of buys
-
15
-
Number of sells
-
-20
-
Price
-
$2.75
Significant Holders of OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR) as of Q3 2025
50 filings reported holding OKUR - OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share as of Q3 2025.
OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.2M shares
of 12.9M outstanding shares and own 79.49% of the company stock.
Largest 10 shareholders include ACORN CAPITAL ADVISORS, LLC (2.84M shares), CITADEL ADVISORS LLC (1.02M shares), Shay Capital LLC (918K shares), VANGUARD GROUP INC (678K shares), HIGHBRIDGE CAPITAL MANAGEMENT LLC (650K shares), Vestal Point Capital, LP (635K shares), BlackRock, Inc. (565K shares), StepStone Group LP (492K shares), CANTOR FITZGERALD, L. P. (492K shares), and NEA Management Company, LLC (479K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.